BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10442373)

  • 41. A phase I study of paclitaxel, UFT, and leucovorin.
    Gojo I; Tkaczuk KH
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):76-8. PubMed ID: 11098500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
    Meropol NJ; Noel D; Sonnichsen DS; Birkhofer MJ
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):22-5. PubMed ID: 9348562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
    González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
    Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UFT plus leucovorin for metastatic colorectal cancer: Japanese experience.
    Ichikawa W; Nihei Z; Uetake H; Yamada H; Shirota Y; Sugihara K
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):41-3. PubMed ID: 11098491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
    Ferrero JM; Largillier R; Michel C; Amiot V; Milano G; Hébert C; Mari V; Courdi A; Figl A; Follana P; Barrière J; Chamorey E
    Oncology; 2011; 81(2):73-8. PubMed ID: 21968516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
    Rosati G; Cordio S; Tucci A; Blanco G; Bordonaro R; Reggiardo G; Manzione L
    Oncology; 2005; 69(2):122-9. PubMed ID: 16118508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
    Bin Q; Li J; Liao C; Cao Y; Gao F
    Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
    Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
    Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review.
    Minsky BD
    Int J Cancer; 2001 Feb; 96(1):1-10. PubMed ID: 11241325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
    Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
    J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
    Takada A; Kawahara M; Kobayashi H; Takino Y; Kodama T; Sugishita T; Ohno Y; Oka T; Tsukamoto F
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):997-9. PubMed ID: 22705701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
    Thongprasert S; Maoleekoonpairoj S; Laohavinij S; Thavichaigarn P
    J Med Assoc Thai; 2000 Jun; 83(6):676-80. PubMed ID: 10932496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
    Feliu J; González Barón M; Zamora P; Garcia Alfonso P; Garcia Girón C; Blanco E; Belón J; Garrido P; Jara C; Ruiz A; Vincent JM; Espinosa E
    Oncology; 1997; 54 Suppl 1():30-7. PubMed ID: 8978582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gemcitabine and UFT plus oral calcium folinate: phase I study.
    Philip PA; Ibrahim D; Zalupski M; Arlauskas P; Shields A
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):116-9. PubMed ID: 10442378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UFT: East meets West in drug development.
    Pazdur R
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):11-3. PubMed ID: 9348560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.